10X Genomics Inc (TXG) Stock Price, Quote & News

Company Profile

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and singl...

Industry: Medical Devices

Sector: Healthcare

Phone: 925 401 7300

Website: www.10xgenomics.com

Address:

6230 Stoneridge Mall Road, Pleasanton, United States

IN0V8 Sep. 1 at 4:11 PM

$TXG RBC initiates coverage with sector perform rating; PT $70

0 · Reply

durocali Aug. 28 at 6:42 PM

$TXG receives favorable patent ruling: https://www.stocktitan.net/news/TXG/10x-genomics-wins-patent-infringement-verdict-against-parse-aa3t0eagc2ov.html

0 · Reply

MahiMe Aug. 28 at 6:41 PM

$TXG 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences

0 · Reply

yesitrade Aug. 28 at 4:01 PM

$TXG Quickly approaching my reentry point. (This has been my best trade this year)

2 · Reply

WAJeff Aug. 28 at 4:03 AM

$TXG This and $TWST just went off without much fanfare. TXG beyond my wildest expectations.

0 · Reply

SilverEagle Aug. 27 at 3:33 PM

$TXG would like to say I still have them but I sold at 50. one day you’ll know.

0 · Reply

egcgfiend Aug. 25 at 8:16 PM

$PACB $TXG genetic read write baby lfg

0 · Reply

egcgfiend Aug. 25 at 2:44 PM

$PACB banker id1ot dogs severely underestimated the importance of SMRT to future of humanity, now this squeeze will make us all rich. buy buy buy and get Sh1tling to pay for your retirement! @MingLin $TXG $TWST

0 · Reply

PensionPulse Aug. 21 at 10:30 PM

$SPY $MRNA $AMLX $IOVA $TXG My latest coverage of top funds' activity in Q2 2026: https://pensionpulse.blogspot.com/2026/08/top-funds-activity-in-q2-2026.html

0 · Reply

LongStoryShortsky Aug. 20 at 1:02 AM

$TXG smells like an offering, they need money

1 · Reply

10x Genomics initiated with a Sector Perform at RBC Capital

2026-08-28T18:45:12.000Z - 10 days ago

10x Genomics reports patent infringement win against Parse Biosciences

QGEN

Aug 28, 2026, 2:38 PM EDT - 10 days ago

10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences

QGEN

2026-08-17T09:25:26.000Z - 22 days ago

10x Genomics price target raised to $65 from $50 at Stephens

2026-08-10T11:25:26.000Z - 4 weeks ago

10x Genomics price target raised to $60 from $50 at Canaccord

2026-08-10T11:20:47.000Z - 4 weeks ago

10x Genomics price target raised to $47 from $42 at Piper Sandler

2026-08-07T13:25:30.000Z - 4 weeks ago

10x Genomics price target raised to $40 from $37 at Morgan Stanley

2026-08-07T13:05:27.000Z - 4 weeks ago

10x Genomics price target raised to $50 from $25 at Stifel

2026-08-07T11:01:03.000Z - 4 weeks ago

10x Genomics price target raised to $50 from $45 at Citi

Aug 6, 2026, 4:30 PM EDT - 4 weeks ago

10x Genomics Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 4 weeks ago

10x Genomics Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 4 weeks ago

10x Genomics Quarterly report: Q2 2026

2026-08-06T20:18:44.000Z - 4 weeks ago

10x Genomics reports Q2 EPS (14c), consensus (2c)

2026-08-06T20:18:09.000Z - 4 weeks ago

10x Genomics raises 2026 revenue view to $610M-$630M from $600M-$625M

Aug 6, 2026, 4:02 PM EDT - 4 weeks ago

10x Genomics Reports Second Quarter 2026 Financial Results

2026-07-29T13:11:04.000Z - 5 weeks ago

10x Genomics announces research collaboration with Lausanne University Hospital

Jul 29, 2026, 9:00 AM EDT - 5 weeks ago

10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care

2026-07-17T12:45:11.000Z - 7 weeks ago

10x Genomics price target raised to $40 from $23 at Leerink

Jul 15, 2026, 4:05 PM EDT - 7 weeks ago

10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026

2026-07-15T12:46:15.000Z - 7 weeks ago

10x Genomics price target raised to $47 from $25 at TD Cowen

2026-07-14T11:00:55.000Z - 1 month ago

10x Genomics price target raised to $50 from $32 at Canaccord

2026-07-09T11:00:55.000Z - 2 months ago

10x Genomics price target raised to $37 from $22 at Morgan Stanley

Jul 8, 2026, 3:07 PM EDT - 2 months ago

10x Genomics Transcript: Transcript

2026-07-08T10:45:32.000Z - 2 months ago

10x Genomics price target raised to $45 from $24 at Citi

Jun 17, 2026, 5:00 PM EDT - 2 months ago

Torex Gold Announces Results of Its 2026 Meeting of Shareholders

Jun 17, 2026, 9:00 AM EDT - 2 months ago

10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer

ADC

Jun 9, 2026, 9:00 AM EDT - 3 months ago

10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group

May 13, 2026, 8:00 PM EDT - 3 months ago

10x Genomics Transcript: Bank of America Global Healthcare Conference 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

10x Genomics Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

10x Genomics Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

10x Genomics Quarterly report: Q1 2026

May 7, 2026, 4:05 PM EDT - 4 months ago

10x Genomics Reports First Quarter 2026 Financial Results

Apr 29, 2026, 4:05 PM EDT - 4 months ago

10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference

Apr 24, 2026, 8:00 AM EDT - 4 months ago

10x Genomics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

10x Genomics Proxy statement: Proxy filing

Apr 23, 2026, 7:00 AM EDT - 4 months ago

LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor

Apr 18, 2026, 10:00 PM EDT - 4 months ago

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

Apr 17, 2026, 7:00 AM EDT - 4 months ago

10x Genomics Slides: Corporate presentation

Apr 15, 2026, 4:05 PM EDT - 4 months ago

10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026

Mar 25, 2026, 7:00 AM EDT - 5 months ago

Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs

Mar 17, 2026, 8:00 AM EDT - 5 months ago

PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas

Mar 3, 2026, 11:50 AM EST - 6 months ago

10x Genomics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 19, 2026, 4:05 PM EST - 6 months ago

10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference

Feb 12, 2026, 4:30 PM EST - 6 months ago

10x Genomics Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

10x Genomics Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

10x Genomics Earnings release: Q4 2025

Feb 12, 2026, 4:05 PM EST - 6 months ago

10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026

Feb 4, 2026, 9:00 AM EST - 7 months ago

PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology

Jan 22, 2026, 4:05 PM EST - 7 months ago

10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

Jan 12, 2026, 11:15 AM EST - 7 months ago

10x Genomics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 11:15 AM EST - 7 months ago

10x Genomics Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 9:11 AM EST - 7 months ago

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

Jan 12, 2026, 9:10 AM EST - 7 months ago

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Jan 12, 2026, 9:00 AM EST - 7 months ago

Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

Jan 11, 2026, 12:00 PM EST - 7 months ago

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

Jan 7, 2026, 7:05 AM EST - 8 months ago

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CDNA

Dec 29, 2025, 4:05 PM EST - 8 months ago

10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nov 18, 2025, 11:20 AM EST - 9 months ago

10x Genomics Transcript: Wolfe Research Healthcare Conference 2025

Nov 18, 2025, 9:00 AM EST - 9 months ago

New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium

Nov 11, 2025, 4:05 PM EST - 10 months ago

10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

10x Genomics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

10x Genomics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

10x Genomics Earnings release: Q3 2025

Nov 6, 2025, 4:05 PM EST - 10 months ago

10x Genomics Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 9:00 AM EDT - 10 months ago

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research

Oct 20, 2025, 12:30 PM EDT - 10 months ago

10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences

Oct 9, 2025, 4:05 PM EDT - 11 months ago

10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 9, 2025, 8:00 AM EDT - 11 months ago

Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent

Sep 10, 2025, 11:30 AM EDT - 12 months ago

10x Genomics Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 9:00 AM EDT - 12 months ago

CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics

Aug 27, 2025, 4:05 PM EDT - 1 year ago

10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 19, 2025, 9:00 AM EDT - 1 year ago

10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis

Aug 7, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings release: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 1 year ago

10x Genomics Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:04 PM EDT - 1 year ago

10x Genomics to Acquire Scale Biosciences

Jul 17, 2025, 9:00 AM EDT - 1 year ago

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

Jul 10, 2025, 4:05 PM EDT - 1 year ago

10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025

May 14, 2025, 4:05 PM EDT - 1 year ago

10x Genomics Announces Patent Litigation Settlement Agreement with Bruker

May 13, 2025, 2:20 PM EDT - 1 year ago

10x Genomics Transcript: Bank of America 2025 Healthcare Conference

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings release: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

10x Genomics Reports First Quarter 2025 Financial Results

Apr 30, 2025, 4:05 PM EDT - 1 year ago

10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference

Apr 15, 2025, 8:00 AM EDT - 1 year ago

10x Genomics Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

10x Genomics Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Vizgen Announces End of Litigation with 10x Genomics and Harvard University

Mar 4, 2025, 11:10 AM EST - 1 year ago

10x Genomics Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 4:05 PM EST - 1 year ago

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products

Feb 23, 2025, 11:30 AM EST - 1 year ago

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis

Feb 18, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference

Feb 12, 2025, 7:19 PM EST - 1 year ago

Trump's Cuts to Medical Research Are Hurting These Stocks

ILMN PACB

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Earnings Call Transcript: Q4 2024

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Annual report: Q4 2024

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Earnings release: Q4 2024

Feb 12, 2025, 4:05 PM EST - 1 year ago

10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025

Feb 6, 2025, 8:30 AM EST - 1 year ago

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology

Feb 4, 2025, 8:59 AM EST - 1 year ago

Parse Biosciences Invalidates All 10x Genomics' Patent Claims Asserted Against Its Products

Jan 31, 2025, 6:34 AM EST - 1 year ago

Spatial Omics Research Report 2023-2034: Market to reach $1.09 Billion - 10x Genomics Enhances Spatial OMICS with New Visium Spatial Gene Expression for FFPE

IN0V8 Sep. 1 at 4:11 PM

$TXG RBC initiates coverage with sector perform rating; PT $70

0 · Reply

durocali Aug. 28 at 6:42 PM

$TXG receives favorable patent ruling: https://www.stocktitan.net/news/TXG/10x-genomics-wins-patent-infringement-verdict-against-parse-aa3t0eagc2ov.html

0 · Reply

MahiMe Aug. 28 at 6:41 PM

$TXG 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences

0 · Reply

yesitrade Aug. 28 at 4:01 PM

$TXG Quickly approaching my reentry point. (This has been my best trade this year)

2 · Reply

WAJeff Aug. 28 at 4:03 AM

$TXG This and $TWST just went off without much fanfare. TXG beyond my wildest expectations.

0 · Reply

SilverEagle Aug. 27 at 3:33 PM

$TXG would like to say I still have them but I sold at 50. one day you’ll know.

0 · Reply

egcgfiend Aug. 25 at 8:16 PM

$PACB $TXG genetic read write baby lfg

0 · Reply

egcgfiend Aug. 25 at 2:44 PM

0 · Reply

PensionPulse Aug. 21 at 10:30 PM

$SPY $MRNA $AMLX $IOVA $TXG My latest coverage of top funds' activity in Q2 2026: https://pensionpulse.blogspot.com/2026/08/top-funds-activity-in-q2-2026.html

0 · Reply

LongStoryShortsky Aug. 20 at 1:02 AM

$TXG smells like an offering, they need money

1 · Reply

egcgfiend Aug. 19 at 8:43 PM

$PACB $TXG $TWST $MRNA cure all disease and aging wooooooooo

1 · Reply

WAJeff Aug. 19 at 7:15 PM

$TXG Quick flip from 59.51 to 60.98, 61.84 52 week high

0 · Reply

BoTom58 Aug. 19 at 4:28 PM

$TXG Great company and tech… very overvalued though in my opinion

1 · Reply

MaverikIT Aug. 17 at 7:53 PM

@cynicaloptimist @Jblack500 @WAJeff let's $TWST and $PLSE ing again $NTRA $TXG ...

1 · Reply

LongStoryShortsky Aug. 12 at 9:40 PM

$TXG next stop 50

2 · Reply

strassburg Aug. 11 at 11:06 PM

$TXG In at 32. Man, it’s hard not to sell right now, but i love this company long. May sell half and secure some profit. What u guys think?

2 · Reply

Pika_Capital Aug. 11 at 8:21 PM

$SEER $CDXS $QTRX $TXG Lmao entire life sciences landscape is a total joke. Tons of garbage is trading at 90% discount. Some of these down the road will recover but most of them will disappear

1 · Reply

Lowkeyoptions Aug. 10 at 7:29 PM

$TXG $TENX just wait for the move lol. You have the three legged horse not 4

0 · Reply

manojaggarwal Aug. 10 at 7:28 PM

$TXG dude I thought I had this in my portfolio but I have $TENX instead 😢 I done messed up 😭

1 · Reply

IN0V8 Aug. 10 at 5:18 PM

$TXG Canaccord Genuity raises target price to $60 from $50

0 · Reply

WAJeff Aug. 10 at 3:38 PM

$TXG 7/1 39s sold at 56

0 · Reply

WAJeff Aug. 10 at 2:03 PM

$TXG Quite the year here

2 · Reply

Market Cap	8.16B
Revenue (ttm)	642.82M
Net Income (ttm)	-43.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-6.77%
Debt to Equity Ratio	0.00

Volume	1,469,800
Avg Vol	3,080,600
Day's Range	N/A - N/A
Shares Out	130.29M
Stochastic %K	48%
Beta	2.08
Analysts	Sell
Price Target	$50.00